industry

J&J agrees to pay only Rs 25 lakh compensation for faulty hip implants


On Monday US device maker Johnson and Johnson (J&J) agreed to pay a compensation of Rs 25 lakh to patients who received the faulty hip implants.

J&J statement to the Delhi HC comes a month after the drug controller directed the company to pay up two patients in Maharashtra Rs 65 lakh and Rs 74 lakh, respectively. In March this year, a committee under Dr Arun Kumar Agarwal submitted its report to the health ministry with its final recommendation.

After consultation with various state and central governments, the drug regulator announced that it came to the compensation figure of Rs 74.5 lakh.

A company official told ET that it has also challenged this circular of the drug regulator on the grounds that the regulator has no jurisdiction under the drugs and cosmetics act.

The Maharashtra state drug regulator received an application from one patient of the state over the faulty implant from J&J. The drug regulator said after recommendations from the state-level committee it came to the conclusion that the patient was implanted with faulty ASR hip implant in both hips and subsequent revision of left hip and is entitled for the financial compensation as per the formula.





READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.